Workflow
WSJ
icon
Search documents
Nvidia CEO Says He Doesn't Care About California's Proposed Billionaire Tax
WSJ· 2026-01-06 21:11
Core Viewpoint - The proposal has generated significant backlash from other ultrawealthy residents, who are concerned about a potential exodus from the state [1] Group 1 - The proposal has sparked outrage among ultrawealthy residents [1] - Concerns have been raised regarding the potential impact on the state's population dynamics [1]
Eli Lilly is in advanced talks to acquire Ventyx Biosciences for more than $1 billion, according to people familiar with the matter
WSJ· 2026-01-06 20:40
Group 1 - The deal is valued at more than $1 billion and is expected to be finalized imminently [1]
OneStream to Go Private Through $6.4 Billion Hg Acquisition
WSJ· 2026-01-06 19:18
Group 1 - OneStream shareholders will receive $24 a share, representing a 31% premium over Monday's closing price [1]
Hilton Removes Hotel From Its System After It Refuses Service to ICE Agents
WSJ· 2026-01-06 18:39
Core Viewpoint - The hotel chain has removed its Minneapolis property from booking channels following allegations from the Department of Homeland Security regarding the cancellation of rooms for its agents [1] Group 1 - The hotel chain's action was a direct response to allegations made by the Department of Homeland Security [1] - The cancellation of rooms for agents has raised concerns about the hotel's operational practices [1]
Eli Lilly, Nimbus Partner to Develop, License Oral Obesity Treatment
WSJ· 2026-01-06 17:38
Core Insights - Eli Lilly and Nimbus Therapeutics have established a multiyear collaboration and exclusive licensing agreement aimed at developing an oral treatment for obesity and other metabolic diseases [1] Company Summary - Eli Lilly is focusing on expanding its portfolio in the obesity treatment market through this collaboration with Nimbus Therapeutics [1] - Nimbus Therapeutics is leveraging its expertise in drug development to partner with Eli Lilly for innovative solutions in metabolic diseases [1] Industry Summary - The collaboration highlights the growing interest and investment in treatments for obesity and metabolic diseases, which are significant health concerns globally [1] - The agreement reflects a trend in the pharmaceutical industry towards partnerships to accelerate drug development and bring new therapies to market [1]
Fed's Miran Hasn't Spoken With Trump About Fed Chair Job
WSJ· 2026-01-06 16:25
Federal Reserve Governor Stephen Miran said he is not among the finalists President Trump is considering for the Fed chair role and hasn't raised his hand for the job. ...
Treasury Yields Rise; Repo Funding Threat Subsides
WSJ· 2026-01-06 15:42
Core Viewpoint - U.S. Treasury yields increased as the market faced reduced pressure from year-end funding issues in the repo market [1] Group 1 - U.S. Treasury yields experienced an uptick, indicating a shift in market dynamics [1] - The year-end funding pressure in the repo market, which had been a concern, has started to recede, contributing to the rise in yields [1]
Meta Pauses European Rollout of Smart Ray-Bans as Americans Lap Up Supply
WSJ· 2026-01-06 14:38
Core Insights - The Ray-Ban Display smartglasses are developed in collaboration with EssilorLuxottica and were initially planned for release in Canada, France, the U.K., and Italy [1] Group 1 - The smartglasses represent a significant step in the integration of technology and fashion eyewear [1] - The partnership with EssilorLuxottica highlights the trend of traditional eyewear companies venturing into smart technology [1] - The anticipated launch in multiple countries indicates a strategic approach to capture a diverse market [1]
Ford Sales Rise on Increased Demand for Lower-Priced Trucks
WSJ· 2026-01-06 14:36
Ford recorded more fourth-quarter sales compared with the prior year, as lower-priced truck sales helped it more than offset a decline in electric vehicles. ...
AIG Taps Aon's Eric Andersen to Succeed Peter Zaffino as CEO
WSJ· 2026-01-06 13:06
Core Viewpoint - American International Group's chairman and chief executive, Peter Zaffino, is set to retire as chief executive in midyear, with Eric Andersen, a longtime executive from Aon, taking over the position [1] Company Transition - Peter Zaffino will step down from his role as chief executive in midyear [1] - Eric Andersen, who has extensive experience at Aon, will succeed Zaffino as the new chief executive [1]